Your browser doesn't support javascript.
loading
Prevalence and characteristics of myeloproliferative neoplasms with concomitant monoclonal gammopathy.
Javorniczky, Nora Rebeka; Wehrle, Julius; Ihorst, Gabriele; Hupfer, Valerie; Aumann, Konrad; Pfeifer, Dietmar; Niemöller, Christoph; Bleul, Sabine; Pantic, Milena; Werner, Martin; Duyster, Justus; Finke, Jürgen; Engelhardt, Monika; von Bubnoff, Nikolas; Waller, Cornelius F; Pahl, Heike L; Becker, Heiko.
Afiliação
  • Javorniczky NR; Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Germany.
  • Wehrle J; Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Germany; German Cancer Consortium (DKTK) Partner Site, Freiburg, Germany.
  • Ihorst G; Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Germany; Clinical Trials Unit, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Germany.
  • Hupfer V; Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Germany.
  • Aumann K; Department of Pathology, Medical Center - University of Freiburg, Faculty of Medicine, Freiburg, Germany.
  • Pfeifer D; Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Germany.
  • Niemöller C; Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Germany.
  • Bleul S; Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Germany.
  • Pantic M; Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Germany.
  • Werner M; German Cancer Consortium (DKTK) Partner Site, Freiburg, Germany; Department of Pathology, Medical Center - University of Freiburg, Faculty of Medicine, Freiburg, Germany.
  • Duyster J; Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Germany; German Cancer Consortium (DKTK) Partner Site, Freiburg, Germany.
  • Finke J; Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Germany.
  • Engelhardt M; Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Germany.
  • von Bubnoff N; Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Germany; German Cancer Consortium (DKTK) Partner Site, Freiburg, Germany; Department of Hematology and Oncology, Medical Center, University of Schleswig-Holstein, Campus Lübeck, Germany.
  • Waller CF; Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Germany.
  • Pahl HL; Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Germany.
  • Becker H; Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Germany; German Cancer Consortium (DKTK) Partner Site, Freiburg, Germany. Electronic address: heiko.becker@uniklinik-freiburg.de.
Leuk Res ; 98: 106454, 2020 11.
Article em En | MEDLINE | ID: mdl-32971364

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Gamopatia Monoclonal de Significância Indeterminada / Neoplasias Hematológicas / Transtornos Mieloproliferativos Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Gamopatia Monoclonal de Significância Indeterminada / Neoplasias Hematológicas / Transtornos Mieloproliferativos Idioma: En Ano de publicação: 2020 Tipo de documento: Article